drugset / Trial / NCT01996527
3T MRI Biomarkers of Glioma Treatment Response
Phase 0
Terminated
7 enrolled
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This pilot clinical trial studies advanced magnetic resonance imaging (MRI) techniques in measuring treatment response in patients with high-grade glioma. New diagnostic procedures, such as advanced MRI techniques at 3 Tesla, may be more effective than standard MRI in measuring treatment response in patients receiving treatment for high-grade gliomas.
Timeline
- Start
- 2012-05
- Primary completion
- 2015-11-23
- Completion
- 2016-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Gadopentetate dimeglumine | Diagnostic / imaging agent | — | Intravenous |